賓仕國際(01705.HK)盈警:預期中期純利同比減少約35.0%至45.0%
格隆匯11月11日丨賓仕國際(01705.HK)公吿,根據集團截至2024年9月30日止6個月("期間")未經審核綜合管理賬目及公司董事會目前可取得其他資料所作出初步評估,估計集團於期間純利將錄得約35.0%至45.0%跌幅,而截至2023年9月30日止6個月純利則約為1780萬港元。
期間純利大幅減少乃主要由零售業務及分銷業務收益及毛利減少所導致。此乃由於香港消費市場疲弱所致。挑戰重重經濟加上離港消費增加,嚴重影響本地消費者行為。此外,經濟不確定性亦導致消費者出現負面情緒,進一步影響公司的銷售額。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.